Telephone-Delivered Acceptance and Commitment Therapy for Smoking Cessation
电话提供的戒烟接受和承诺疗法
基本信息
- 批准号:9182880
- 负责人:
- 金额:$ 73.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressAdoptedAdultAfrican AmericanBehavior TherapyBudgetsCessation of lifeCigaretteCognitive TherapyCost MeasuresCounselingCuesDataEffectivenessEmotionsEsthesiaHealth Care CostsInterventionLifeMediatingMediationMedicalMental HealthModalityModelingNational Institute of Drug AbuseOutcomeParticipantPharmacotherapyPopulationPrevalenceProcessProductivityPublic HealthQuality-Adjusted Life YearsRandomizedResearchSample SizeSavingsSmokerSmokingSubgroupSymptomsTelephoneTestingTheoretical modelTherapeutic InterventionThinkingTobaccobasebehavior changebehavioral outcomecomparative effectivenesscostcost effectivecost effectivenesscravingeffective interventioneffectiveness trialexperiencefollow-uphealth disparityimprovedincremental cost-effectivenessinnovationnamed groupnicotine replacementnovelprematurepsychologicpublic health relevancequitlinerandomized trialsatisfactionsmoking cessationsmoking interventionsuccesstheorieswillingness
项目摘要
DESCRIPTION (provided by applicant): Smoking cessation telephone quit lines (QLs), available in all 50 states; now serve over 500,000 smokers each year. On average, only 14% (range: 8% to 20%) of QL callers stop smoking by the 12 month follow-up even with the aid of traditional Cognitive Behavioral Therapy (CBT) combined with pharmacotherapy (typically nicotine replacement therapy; NRT). The low quit rates of QLs stifle their great potential public health impact. To address the low quit rate problem, and thereby start a new research paradigm focused on innovative QL behavioral intervention content, we propose to test a novel counseling approach, called Acceptance & Commitment Therapy (ACT), as a telephone-delivered quit smoking intervention. We recently completed a small (N = 121) NIDA R21 pilot randomized QL trial of proactively-delivered ACT vs. CBT in state QL callers that was underpowered due to R21 budget limits. Results showed that ACT: (1) was feasible to implement and evaluate in a state QL context, (2) had higher participant engagement and satisfaction than CBT, (3) had higher levels of acceptance of cravings than CBT, which in turn predicted quitting smoking, and (4) had higher (albeit non-significant) 6-month post randomization quit rates than CBT. Building on these promising and non- definitive results, a comparative effectiveness randomized trial with a large and fully-powered sample size (N = 1168) and longer term follow-up (i.e., 12 months) is now needed to definitively determine whether telephone- delivered ACT: (1) provides higher quit rates than CBT, (2) operates according to its theory-based mechanisms, and (3) is more cost-effective than CBT. Accordingly, we propose to conduct a randomized comparative effectiveness trial of telephone-delivered ACT counseling plus NRT (n=584) versus telephone-delivered traditional CBT counseling plus NRT (n=584) in state quit line callers, in order to demonstrate that telephone-delivered ACT: (1) has significantly higher 30-day point prevalence abstinence at 12 months post-randomization than telephone-delivered traditional CBT; (2) has smoking cessation outcomes significantly mediated by three psychological processes central to the theoretical model underlying ACT: acceptance of internal (a) sensations, (b) emotions, and (c) thoughts that cue smoking; (3) Will be significantly more cost-effective than telephone-delivered CBT, as measured by cost per additional quitter, incremental cost-effectiveness (ICER), and incremental cost per quality-adjusted life year (QALY). The study, well-motivated by preliminary results, shows exciting promise for improving the success rates of quit lines and thereby lowering healthcare costs and reducing premature tobacco-related deaths. If shown to be efficacious and cost-effective, ACT would provide the scientific field a new conceptual model of QL intervention and quit lines a new treatment approach that could help 45,000 more (of the 500,000) quit line callers to stop smoking each year, thereby saving in medical costs and prolonging lives.
描述(由申请人提供):戒烟电话戒烟热线(QLs),在所有50个州提供;现在每年为50多万吸烟者提供服务。平均而言,只有14%(范围:8%至20%)的QL呼叫者在12个月随访时停止吸烟,即使在传统认知行为疗法(CBT)联合药物治疗(通常为尼古丁替代疗法; NRT)的帮助下。QLs的低退出率扼杀了他们巨大的潜在公共卫生影响。为了解决低戒烟率的问题,从而开始一个新的研究范式,专注于创新的QL行为干预的内容,我们建议测试一种新的咨询方法,称为接受与承诺疗法(ACT),作为一个电话提供戒烟干预。我们最近完成了一项小型(N = 121)NIDA R21试点随机QL试验,在州QL呼叫者中主动提供ACT与CBT,由于R21预算限制,该试验动力不足。结果显示,ACT:(1)在州QL背景下实施和评估是可行的,(2)参与者参与度和满意度高于CBT,(3)接受渴望的程度高于CBT,这反过来又预测了戒烟,(4)随机化后6个月的戒烟率高于CBT(尽管不显著)。基于这些有希望的和非确定性的结果,一项具有较大和完全把握度的样本量(N = 1168)和长期随访(即,12个月),现在需要明确确定是否电话交付ACT:(1)提供比CBT更高的戒烟率,(2)根据其基于理论的机制运作,(3)比CBT更具成本效益。因此,我们建议在州戒烟热线呼叫者中进行一项电话传递ACT咨询加NRT(n=584)与电话传递传统CBT咨询加NRT(n=584)的随机比较有效性试验,以证明电话传递ACT:(1)在随机化后12个月时,30天时点戒烟率显著高于电话传递传统CBT;(2)戒烟结果显著受ACT理论模型核心的三个心理过程介导:接受内部(a)感觉,(B)情绪和(c)提示吸烟的想法;(3)将比电话提供的CBT更具成本效益,如每个额外戒烟者的成本,增量成本效益(ICER),每质量调整生命年(QALY)的增量成本。这项研究受到初步结果的充分激励,显示出令人兴奋的提高戒烟成功率的前景,从而降低医疗成本并减少与烟草相关的过早死亡。如果被证明是有效的和具有成本效益的,ACT将为科学领域提供一个新的QL干预概念模型,戒烟热线是一种新的治疗方法,每年可以帮助45,000多名(500,000名)戒烟热线呼叫者戒烟,从而节省医疗费用并延长生命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan B Bricker其他文献
Parental smoking cessation and children's smoking: response to three insightful commentaries
父母戒烟和儿童吸烟:对三个富有洞察力的评论的回应
- DOI:
10.1046/j.1360-0443.2003.t01-9-00396.x - 发表时间:
2003 - 期刊:
- 影响因子:6
- 作者:
Jonathan B Bricker;B. Leroux;A. V. Peterson;Kathleen A. Kealey;I. Sarason;M. Andersen;Patrick M. Marek - 通讯作者:
Patrick M. Marek
A Behavioral Activation Mobile Health App for Smokers With Depression: Development and Pilot Evaluation in a Single-Arm Trial
针对抑郁症吸烟者的行为激活移动健康应用程序:单臂试验的开发和试点评估
- DOI:
10.2196/13728 - 发表时间:
2019 - 期刊:
- 影响因子:2.2
- 作者:
J. Heffner;Noreen L Watson;Edit Serfozo;Kristin E Mull;Laura MacPherson;Melissa L. Gasser;Jonathan B Bricker - 通讯作者:
Jonathan B Bricker
The Paradox of Avoidant Coping and Its Implications for Smoking Does Avoidant Coping Influence Young Adults’ Smoking?: A Ten-Year Longitudinal Study
回避型应对的悖论及其对吸烟的影响回避型应对会影响年轻人吸烟吗?:一项为期十年的纵向研究
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Jonathan B Bricker;Lara B. Schiff;B. Comstock - 通讯作者:
B. Comstock
Jonathan B Bricker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan B Bricker', 18)}}的其他基金
Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial
针对全国招募的美洲印第安人和阿拉斯加原住民的数字戒烟干预:一项全面的随机对照试验
- 批准号:
10826067 - 财政年份:2023
- 资助金额:
$ 73.4万 - 项目类别:
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking
Quit2Heal:智能手机应用程序帮助癌症患者戒烟的严格随机试验
- 批准号:
10601285 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss
电话送达验收
- 批准号:
10176479 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss
电话送达验收
- 批准号:
10448324 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking
Quit2Heal:智能手机应用程序帮助癌症患者戒烟的严格随机试验
- 批准号:
10646486 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation
创新对话式戒烟剂的全面随机试验
- 批准号:
10640842 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking
Quit2Heal:智能手机应用程序帮助癌症患者戒烟的严格随机试验
- 批准号:
10413165 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss
电话送达验收
- 批准号:
10686832 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss
电话送达验收
- 批准号:
10601644 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation
创新对话式戒烟剂的全面随机试验
- 批准号:
10381470 - 财政年份:2020
- 资助金额:
$ 73.4万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 73.4万 - 项目类别:
Research Grant